AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionOppenheimer Asset Management Inc.
Latest Disclosed Ownership181,363 shares
Latest Disclosed Value $ 39,444,640
Oppenheimer Asset Management Inc. reports 3.31% decrease in ownership of ABBV / AbbVie Inc.

On April 23, 2026 - Oppenheimer Asset Management Inc. filed a 13F-HR form disclosing ownership of 181,363 shares of AbbVie Inc. (US:ABBV) valued at $39,444,639 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 187,578 shares of AbbVie Inc.. This represents a change in shares of -3.31% during the quarter. The current value of the position is $41,211,114 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F ABBVIE COM 00287Y109 181,363 -6,215 -3.31 39,445 -7.97 0.1127
2026-02-02 2025-12-31 13F ABBVIE COM 00287Y109 187,578 1,634 0.88 42,860 -0.45 0.5270
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 185,944 4,730 2.61 43,053 28.00 0.4736
2025-07-31 2025-06-30 13F ABBVIE COM 00287Y109 181,214 3,574 2.01 33,637 -9.63 0.3858
2025-04-23 2025-03-31 13F ABBVIE COM 00287Y109 177,640 -6,609 -3.59 37,219 13.68 0.4619
2025-02-05 2024-12-31 13F ABBVIE COM 00287Y109 184,249 -22,638 -10.94 32,741 -19.86 0.3980
2024-11-05 2024-09-30 13F ABBVIE COM 00287Y109 206,887 2,917 1.43 40,856 16.78 0.4919
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 203,970 52,731 34.87 34,985 27.03 0.4469
2024-05-07 2024-03-31 13F ABBVIE COM 00287Y109 151,239 -9,295 -5.79 27,541 10.70 0.4035
2024-02-13 2023-12-31 13F ABBVIE COM 00287Y109 160,534 6,542 4.25 24,878 8.38 0.3461
2023-11-08 2023-09-30 13F ABBVIE COM 00287Y109 153,992 8,437 5.80 22,954 17.05 0.3522
2023-08-03 2023-06-30 13F ABBVIE COM 00287Y109 145,555 -11,952 -7.59 19,611 -21.88 0.2884
2023-05-10 2023-03-31 13F ABBVIE COM 00287Y109 157,507 4,215 2.75 25,102 1.32 0.3866
2023-02-07 2022-12-31 13F ABBVIE COM 00287Y109 153,292 7,652 5.25 24,774 26.73 0.3988
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 145,640 10,345 7.65 19,548 -5.67 0.3448
2022-08-08 2022-06-30 13F ABBVIE COM 00287Y109 135,295 1,897 1.42 20,723 -4.17 0.3472
2022-05-12 2022-03-31 13F ABBVIE COM 00287Y109 133,398 -24,766 -15.66 21,625 0.98 0.3069
2022-02-02 2021-12-31 13F ABBVIE COM 00287Y109 158,164 -509 -0.32 21,415 25.12 0.2839
2021-11-12 2021-09-30 13F ABBVIE COM 00287Y109 158,673 4,393 2.85 17,116 -1.51 0.2434
2021-08-03 2021-06-30 13F ABBVIE COM 00287Y109 154,280 19,286 14.29 17,379 18.96 0.2475
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 134,994 9,754 7.79 14,609 8.88 0.2264
2021-02-11 2020-12-31 13F ABBVIE COM 00287Y109 125,240 2,068 1.68 13,418 24.38 0.2241
2020-11-13 2020-09-30 13F ABBVIE COM 00287Y109 123,172 13,055 11.86 10,788 -0.21 0.2095
2020-08-11 2020-06-30 13F ABBVIE COM 00287Y109 110,117 8,580 8.45 10,811 39.75 0.2231
2020-05-08 2020-03-31 13F ABBVIE COM 00287Y109 101,537 -21,058 -17.18 7,736 -28.73 0.1901
2020-02-07 2019-12-31 13F ABBVIE COM 00287Y109 122,595 -214 -0.17 10,855 16.73 0.2293
2019-10-31 2019-09-30 13F ABBVIE COM 00287Y109 122,809 -5,764 -4.48 9,299 -0.55 0.2066
2019-08-09 2019-06-30 13F ABBVIE COM 00287Y109 128,573 51,430 66.67 9,350 50.39 0.2066
2019-04-24 2019-03-31 13F ABBVIE COM 00287Y109 77,143 -11,565 -13.04 6,217 -23.99 0.1397
2019-01-30 2018-12-31 13F ABBVIE COM 00287Y109 88,708 -3,998 -4.31 8,179 -6.72 0.2026
2018-10-26 2018-09-30 13F ABBVIE COM 00287Y109 92,706 -2,076 -2.19 8,768 -0.16 0.1943
2018-08-10 2018-06-30 13F ABBVIE COM 00287Y109 94,782 -2,392 -2.46 8,782 -4.52 0.2148
2018-05-09 2018-03-31 13F ABBVIE COM 00287Y109 97,174 730 0.76 9,198 7.34 0.2307
2018-02-07 2017-12-31 13F ABBVIE COM 00287Y109 96,444 0 0.00 8,569 0.00 0.2274
2017-11-14 2017-09-30 13F ABBVIE COM 00287Y109 96,444 -58,479 -37.75 8,569 -23.71 0.2226
2017-08-09 2017-06-30 13F ABBVIE COM 00287Y109 154,923 -10,209 -6.18 11,232 4.39 0.3103
2017-05-15 2017-03-31 13F ABBVIE COM 00287Y109 165,132 165,132 10,760 0.3065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.